Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul;21(7):439-49.
doi: 10.1016/j.molmed.2015.04.005. Epub 2015 May 18.

Type 2 diabetes as a protein misfolding disease

Abhisek Mukherjee  1 , Diego Morales-Scheihing  2 , Peter C Butler  3 , Claudio Soto  4
Affiliations
Review

Type 2 diabetes as a protein misfolding disease

Abhisek Mukherjee et al. Trends Mol Med. 2015 Jul.

Abstract

Type 2 diabetes (T2D) is a highly prevalent and chronic metabolic disorder. Recent evidence suggests that formation of toxic aggregates of the islet amyloid polypeptide (IAPP) might contribute to β-cell dysfunction and disease. However, the mechanism of protein aggregation and associated toxicity remains unclear. Misfolding, aggregation, and accumulation of diverse proteins in various organs is the hallmark of the group of protein misfolding disorders (PMDs), including highly prevalent illnesses affecting the central nervous system (CNS) such as Alzheimer's disease (AD) and Parkinson's disease (PD). In this review we discuss the current understanding of the mechanisms implicated in the formation of protein aggregates in the endocrine pancreas and associated toxicity in the light of the long-standing knowledge from neurodegenerative disorders associated with protein misfolding.

Keywords: amyloid; islet amyloid polypeptide; prions; protein misfolding; type 2 diabetes; β cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1. IAPP propensity to form amyloid aggregates
A: The figure shows a schematic representation of the typical kinetics of human IAPP aggregation compared with other PMD-associated proteins. In our experience, at low micromolar concentrations, physiological temperature and pH, IAPP forms aggregates in minutes, whereas Aβ needs hours and α-synuclein needs days to bypass the lag phase before aggregating exponentially. B: Amyloidogenicity of IAPP from human, rhesus monkey, cat and mouse was studied in silico using a structure-based algorithm originally described by Eisenberg and colleagues [157]. The amino acid sequence is plotted along the X-axis. Each histogram bar represents one hexa-peptide starting at the indicated position in the sequence and is colored according to its Rosetta energy. Orange-red segments with energy below the indicated energetic threshold of −23 kcal/mol (gray line), are predicted to form fibrils.
Figure 2
Figure 2. Molecular pathways implicated in β-cell damage mediated by the formation and accumulation of IAPP aggregates
Illustration of major cellular pathways implicated in the toxicity of IAPP aggregates against β-cells. Figure elements are not drawn to scale. Abbreviations: ER, endoplasmic reticulum; ROS, reactive oxygen species; UPS, ubiquitin proteasome system.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci. 2003;4:49–60. - PubMed
    1. Hardy J, Gwinn-Hardy K. Genetic classification of primary neurodegenerative disease. Science. 1998;282:1075–1079. - PubMed
    1. Moreno-Gonzalez I, Soto C. Natural animal models of neurodegenerative protein misfolding diseases. Curr Pharm Des. 2012;18:1148–1158. - PubMed
    1. Butler AE, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102–110. - PubMed
    1. Kahn SE, et al. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014;383:1068–1083. - PMC - PubMed

Publication types

MeSH terms

Substances